
Ciprix 750mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Capreomycin (750mg)
Overview Ciprix 750mg Injection
Deltimycin 750mg Injection, an antibiotic, combats multi-drug resistant tuberculosis when administered alongside other medications. Its mechanism involves inhibiting the proliferation of tuberculosis bacteria resistant to standard first-line treatments. Administered intramuscularly by a healthcare provider, it requires consistent, evenly-spaced dosing as directed. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or intensified infection. Potential adverse effects include nephrotoxicity, vertigo, and hearing impairment. Strict adherence to physician instructions is crucial, including scheduled kidney function, audiological, and urinalysis assessments. Report treatment inefficacy or troublesome side effects immediately. Operate machinery or engage in activities demanding focus with caution due to potential dizziness. Pregnancy contraindicates its use; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Ciprix 750mg Injection
Mycobacterium tuberculosis infection
Major Benefits of Ciprix 750mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ciprix 750mg Injection:
- Injection site pain
- Renal dysfunction
- Balance disorder (loss of balance)
- Renal impairment
- Hearing loss
How to use Ciprix 750mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Ciprix 750mg Injection works:
Ciprix 750mg injectable solution is a bactericidal antibiotic that inhibits bacterial proliferation by disrupting the synthesis of vital proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ciprix 750mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Ciprix 750mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Ciprix 750mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
The administration of Ciprix 750mg Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Exercise caution when administering Ciprix 750mg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ciprix 750mg Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Nevertheless, routine liver function tests are advisable for patients exhibiting liver dysfunction.
What if you forget to take Ciprix 750mg Injection :
Omit a Ciprix 750mg Injection dose? Seek medical advice immediately.
Facts to Know About Ciprix 750mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
